PhD Studentship: Role of Ubiquitin in DNA replication and damage

University of Birmingham

Supervisor: Dr Aga Gambus

Project outline:

Every dividing cell needs to duplicate its genome perfectly before cell division. When mistakes happen during replication they do need to be efficiently repaired by DNA damage repair (DDR) mechanisms. Failure to do so can result in cell death or development of mutations leading to cancer. It is essential therefore to understand the mechanism of eukaryotic DNA replication and DDR, how they are regulated in normal cells, how they misregulation contributes to tumorigenesis and how this misregulation can be exploited in the treatment of cancer. The proposed project is focusing on studying how ubiquitylation regulates chromosomal replication and DDR.

Ubiquitylation is a posttranslational modification of substrate proteins by attachment of one or many ubiquitins (small protein). Ubiquitylation is very flexible and versatile and regulates almost every aspect of cell biology. Not surprisingly it is essential for proper DDR and we have shown that polyubiquitylation is essential for a truly enigmatic stage of DNA replication – its termination (Moreno et al. Science, 2014). This project provides therefore and exciting opportunity to follow up this discovery, use established techniques and unravel new essential regulatory roles for this amazing modification.

DNA replication is such a fundamental biological process that it is incredibly well conserved throughout evolution and DDR processes have been studied in many different model systems. The aim of this project is to carry out our work in the best model system available to answer the biological question in mind. We have expertise in the lab using a cell-free system of Xenopus laevis egg extract as it provides a simpler model system to study DNA replication. We also work with human cell lines and collaborate with groups working with buddying yeast S.cerevisiae and worm C.elenags. We use biochemistry, proteomics but also genomic modifications (CRISPR/Cas9), cell biology techniques and microscopy.

Importantly, enzymes attaching ubiquitin to substrates (ubiquitin ligases) and removing it (deubiquitylating enzymes, DUBs) were shown to be druggable. It is essential therefore to consider studied processes and enzymes as potential targets for cancer therapies. Indeed first drugs affecting ubiquitylation regulating DNA replication are now being tested in clinical trials as future cancer therapies.

References:

Moreno SP, Bailey R, Campion N, Herron S, Gambus A.

Polyubiquitylation drives replisome disassembly at the termination of DNA replication.

Science. 2014 Oct 24;346(6208):477-81. doi: 10.1126/science.1253585.

http://www.ncbi.nlm.nih.gov/pubmed/25342805

How to Apply

About the Studentship

This is the Midlands Integrative Biosciences Training Partnership and is a BBSRC funded studentship collaboration between us, Leicester and Warwick. The deadline for BBSRC MIBTP applications is the end of January. Applications are received via the online admissions system. As well as applying online, the applicants should also be advised to check their ability through the MIBTP website and submit a notification form to Warwick.

BBSRC funding is known as the Midlands Integrative Biosciences Training Partnership (MIBTP) and information about the scheme can be found  here

Applicants must have all necessary paperwork completed by the deadline.

Stipend: RCUK standard rate (plus additional travel allowance in year 1 and a laptop)

Share this PhD
     
  Share by Email   Print this job   More sharing options
We value your feedback on the quality of our adverts. If you have a comment to make about the overall quality of this advert, or its categorisation then please send us your feedback
Advert information

Type / Role:

PhD

Location(s):

Midlands of England